Babak Tofighi, MD

Babak Tofighi is an Instructor in the Department of Population Health at the New York University School of Medicine and assistant director of the Addiction Medicine fellowship program at NYU and Bellevue Hospital Center.  Previously he completed a 1-year clinical fellowship in the newly initiated American Board of Addiction Medicine designated Addiction Medicine program at NYU and a 2-year NRSA-funded T32 primary care research fellowship (T32HP22238-01-00). He was during this same period a Research in Addiction Medicine Scholar (R25DA03211), and received additional training in health services research.  At Bellevue Hospital, he has been involved in expanding opioid and alcohol pharmacotherapies in primary care, and served as study physician for CTN-0051 (extended-release naltrexone versus buprenorphine opioid treatment, U10 DA013035) and as co-investigator for an NIH funded trial, extended-release naltrexone versus oral naltrexone for the treatment of alcohol use disorders in primary care (R01AA020836-01). He has also continued to study strategies for integrating mHealth-based interventions in Bellevue’s OBOT program.